Ian T. Bothwell

Interim Chief Executive Officer and Chief Financial Officer at Zeo ScientifiX.

Raised on Zeo ScientifiX filings

$500K

of $5M offered across 1 Form D filing

Company

Biotech · Davie, FL

Perinatal-derived biologics for degenerative diseases

Perinatal-derived biologics for degenerative diseases

Zeo ScientifiX Form D filings
Filed	Security	Sold of offered	Filing
Dec 5, 2025	Equity	$500K/ $5M	Form D

Also named on Zeo ScientifiX filings